Lu-177 PSMA
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lu-177 PSMA, covering 2026-02-27 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function [NA]